Bank of Nova Scotia Buys 19,700 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Bank of Nova Scotia lifted its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 16.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 136,181 shares of the medical device company's stock after purchasing an additional 19,700 shares during the quarter. Bank of Nova Scotia owned about 0.07% of Cooper Companies worth $12,519,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in COO. Fulton Bank N.A. lifted its position in Cooper Companies by 3.0% in the 4th quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company's stock valued at $342,000 after acquiring an additional 109 shares in the last quarter. Torray Investment Partners LLC boosted its position in shares of Cooper Companies by 0.8% during the fourth quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company's stock valued at $1,488,000 after buying an additional 132 shares during the last quarter. Mather Group LLC. increased its holdings in Cooper Companies by 7.4% in the 4th quarter. Mather Group LLC. now owns 1,926 shares of the medical device company's stock worth $177,000 after buying an additional 133 shares in the last quarter. MassMutual Private Wealth & Trust FSB lifted its stake in Cooper Companies by 15.6% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company's stock valued at $93,000 after acquiring an additional 136 shares during the period. Finally, Greenleaf Trust boosted its holdings in shares of Cooper Companies by 5.0% during the 4th quarter. Greenleaf Trust now owns 2,915 shares of the medical device company's stock valued at $268,000 after acquiring an additional 139 shares during the last quarter. 24.39% of the stock is owned by institutional investors.

Remove Ads

Cooper Companies Trading Down 1.2 %

Shares of NASDAQ:COO traded down $0.98 during trading on Tuesday, hitting $77.78. The company had a trading volume of 899,767 shares, compared to its average volume of 1,397,965. The stock has a market cap of $15.55 billion, a price-to-earnings ratio of 39.89, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The company has a fifty day simple moving average of $84.28 and a two-hundred day simple moving average of $94.31. The Cooper Companies, Inc. has a one year low of $69.81 and a one year high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting analysts' consensus estimates of $0.92. The business had revenue of $964.70 million for the quarter, compared to analysts' expectations of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. As a group, equities analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Upgrades and Downgrades

COO has been the topic of several research reports. Needham & Company LLC reissued a "hold" rating on shares of Cooper Companies in a research report on Friday, March 7th. BNP Paribas raised shares of Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Robert W. Baird dropped their price target on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a research note on Friday, March 7th. JPMorgan Chase & Co. decreased their target price on Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a report on Friday, March 7th. Finally, Piper Sandler reissued an "overweight" rating and set a $115.00 price target (down previously from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $110.25.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.